Clinical trial

Open-Label Steroid Reduction Study of Adalimumab With Methotrexate in Patients With Active Rheumatoid Arthritis

NCT00233558

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2005-06-01

PhasePHASE4

Study timeline

Study start (unknown)2005-06-01Date precision: month

Registry last updated2007-04-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Rheumatoid Arthritisunresolved

Interventions

adalimumab (up to 9 months exposure)DRUG

methotrexateDRUG · verified · RxNorm: methotrexate

Sponsors & collaborators

Abbottlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00233558 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.